Published in Acta Pathol Microbiol Immunol Scand C on October 01, 1983
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J Exp Med (1979) 8.32
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A (2001) 5.21
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med (1982) 4.49
Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet (2001) 4.48
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med (1991) 4.43
Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol (1999) 4.15
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med (1986) 4.05
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Relation between income inequality and mortality: empirical demonstration. BMJ (1999) 3.98
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med (1994) 3.94
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med (1982) 3.52
[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic (1987) 3.40
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med (1993) 3.31
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61
Mutational analysis of upstream AUG codons of poliovirus RNA. J Virol (1988) 2.55
Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med (1998) 2.39
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med (1983) 2.24
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun (1997) 2.19
Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol (1987) 2.18
Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci U S A (1986) 2.11
Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. Cell Immunol (1988) 2.08
In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen. J Exp Med (1982) 2.02
Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology (1993) 1.97
Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum (2001) 1.91
Relationship between premature mortality and socioeconomic factors in black and white populations of US metropolitan areas. Public Health Rep (2002) 1.91
Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun (2000) 1.91
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun (1999) 1.90
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Fc-receptor variants of a mouse macrophage cell line. Proc Natl Acad Sci U S A (1979) 1.80
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways. J Immunol (2001) 1.79
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J Exp Med (1987) 1.74
Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand J Immunol (1977) 1.71
The distinctive features of influenza virus infection of dendritic cells. Immunobiology (1998) 1.70
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Separation of human monocytes on density gradients of Percoll. J Immunol Methods (1980) 1.63
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Juvenile chronic arthritis: diagnosis and management of tibio-talar and sub-talar disease. Br J Rheumatol (1997) 1.62
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis (1998) 1.62
Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.61
Insertion and turnover of macrophage plasma membrane proteins. Proc Natl Acad Sci U S A (1979) 1.60
In vitro biosynthesis of cold insoluble globulin (fibronectin) by mouse peritoneal macrophages. FEBS Lett (1979) 1.59
Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol (1994) 1.59
Role of activated macrophages in antibody-dependent lysis of tumor cells. J Exp Med (1980) 1.58
The cytotoxic effect of mouse macrophages on syngeneic and allogeneic erythrocytes. J Exp Med (1973) 1.56
Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J Infect Dis (1996) 1.55
The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis (1993) 1.55
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
The cutaneous infiltrates of leprosy. A transmission electron microscopy study. J Exp Med (1983) 1.51
Use of acupuncture by American physicians. J Altern Complement Med (1997) 1.47
Mass isolation and culture of rat kupffer cells. J Exp Med (1975) 1.47
Group B streptococcal vertebral osteomyelitis with bacteraemia in an adult with no debilitating condition. Scand J Infect Dis (1999) 1.47
Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest (1985) 1.47
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med (1995) 1.46
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. J Child Neurol (2000) 1.44
Changes in total RNA, polyadenylated RNA, and actin mRNA during meiotic maturation of mouse oocytes. Dev Biol (1985) 1.43
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect Immun (1999) 1.43
Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis (1999) 1.40
H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect Immun (1996) 1.39
How Mycobacterium leprae infects peripheral nerves. Lepr Rev (1999) 1.39
Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes. J Exp Med (1993) 1.39
Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci U S A (1999) 1.38
A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis (1998) 1.37
The immunobiology of leprosy. Int Rev Exp Pathol (1986) 1.35
Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice. J Exp Med (1987) 1.34
Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol (1990) 1.34
Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase. J Virol (1986) 1.30
Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes (2000) 1.30
Distribution of lysosomal enzymes in different types of rat liver cells. Exp Cell Res (1976) 1.30
Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol (1993) 1.27
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity. Mol Med (1996) 1.24
Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol (1994) 1.23
The selective binding and transmigration of monocytes through the junctional complexes of human endothelium. J Exp Med (1988) 1.23
The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J Exp Med (1989) 1.22
Macrophage activation in vivo and in vitro. Exp Cell Res (1977) 1.22
VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences. J Virol (1988) 1.22
Evidence for a cytolytic factor released by macrophages. J Exp Med (1974) 1.20
A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood (2001) 1.19
Keratinocyte growth regulation by the products of immune cells. J Exp Med (1988) 1.19
Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 1.18
High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol (1998) 1.18
Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis (1997) 1.18
A technique of nonsuture wound closure with a plastic tissue adhesive. Plast Reconstr Surg (1966) 1.18
On the mechanism of internalization of opsonized particles by rat Kupffer cells in vitro. Exp Cell Res (1976) 1.15
A description of inappropriate hospital stays in selected in-patient services: a study of cases receiving social work services. Soc Work Health Care (2001) 1.15
Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med (1996) 1.13
Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis (1993) 1.12
Difference in the effect of immobilized ligands on the Fc and C3 receptors of mouse peritoneal macrophages in vitro. Scand J Immunol (1978) 1.11
Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun (1995) 1.10
Changes in glycosaminoglycan biosynthesis during differentiation in vitro of human monocytes. Biochem J (1983) 1.09
Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity. Microb Pathog (2000) 1.08
Self-reported health status of immigrants from the former Soviet Union in Israel. Isr Med Assoc J (2001) 1.08
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J Exp Med (1993) 1.08